Diabetic retinopathy screening using deep neural network
Importance There is a burgeoning interest in the use of deep neural network in diabetic retinal screening. Background To determine whether a deep neural network could satisfactorily detect diabetic retinopathy that requires referral to an ophthalmologist from a local diabetic retinal screening progr...
Gespeichert in:
Veröffentlicht in: | Clinical & experimental ophthalmology 2018-05, Vol.46 (4), p.412-416 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Importance
There is a burgeoning interest in the use of deep neural network in diabetic retinal screening.
Background
To determine whether a deep neural network could satisfactorily detect diabetic retinopathy that requires referral to an ophthalmologist from a local diabetic retinal screening programme and an international database.
Design
Retrospective audit.
Participants
Diabetic retinal photos from Otago database photographed during October 2016 (485 photos), and 1200 photos from Messidor international database.
Methods
Receiver operating characteristic curve to illustrate the ability of a deep neural network to identify referable diabetic retinopathy (moderate or worse diabetic retinopathy or exudates within one disc diameter of the fovea).
Main Outcome Measures
Area under the receiver operating characteristic curve, sensitivity and specificity.
Results
For detecting referable diabetic retinopathy, the deep neural network had an area under receiver operating characteristic curve of 0.901 (95% confidence interval 0.807–0.995), with 84.6% sensitivity and 79.7% specificity for Otago and 0.980 (95% confidence interval 0.973–0.986), with 96.0% sensitivity and 90.0% specificity for Messidor.
Conclusions and Relevance
This study has shown that a deep neural network can detect referable diabetic retinopathy with sensitivities and specificities close to or better than 80% from both an international and a domestic (New Zealand) database. We believe that deep neural networks can be integrated into community screening once they can successfully detect both diabetic retinopathy and diabetic macular oedema. |
---|---|
ISSN: | 1442-6404 1442-9071 |
DOI: | 10.1111/ceo.13056 |